Concepedia
Statistics
Publications
7
Citations
832
H-Index
Active since
2006
Affiliations
Infinity Pharmaceuticals (United States)(Current)
Tris Pharma (United States)
AMAG Pharmaceuticals (United States)
Jennifer Hoyt is an author at Infinity Pharmaceuticals (United States) specializing in pharmacology, medicine, and drug discovery.
Publications per year
2006–2016
PI3K-δ and PI3K-γ Inhibition by IPI-145 Abrogates Immune Responses and Suppresses Activity in Autoimmune and Inflammatory Disease Models
David G. Winkler, Jonathan P. DiNitto, Janid A. Ali et al. · Chemistry & Biology · 2013 · 258 citations
Life Sciences, Immunology, Pathology +15
Discovery of a Potent and Orally Active Hedgehog Pathway Antagonist (IPI-926)
Martin Tremblay, André Lescarbeau, Michael J. Grogan et al. · Journal of Medicinal Chemistry · 2009 · 251 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +17
Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate
Catherine A. Evans, Tao Liu, André Lescarbeau et al. · ACS Medicinal Chemistry Letters · 2016 · 151 citations · Full text
Medicine, Pharmacokinetics, Pharmacology +11
Semisynthetic Cyclopamine Analogues as Potent and Orally Bioavailable Hedgehog Pathway Antagonists
Martin Tremblay, Marta Nevalainen, Somarajan Nair et al. · Journal of Medicinal Chemistry · 2008 · 107 citations
Pharmacy, Medicinal Chemistry, Pharmacology +13
Suppression of inflammation and structural damage in experimental arthritis through molecular targeted therapy with PPI‐2458
Gerhard Hannig, Sylvie G. Bernier, Jennifer Hoyt et al. · Arthritis & Rheumatism · 2007 · 29 citations
Medicine, Medicinal Chemistry, Pharmacology +16
1–5 of 7